Filter results
You can narrow down the results using the filters
Topic
- Advertising (214)
- COVID-19 (117)
- Medicines safety (93)
- COVID-19 vaccines (70)
- Prescription medicines (69)
- Regulatory compliance (69)
- Legislation (61)
- Medicines (56)
- Medical devices safety (35)
- Listed medicines (33)
- Medical devices (33)
- Non-prescription medicines (28)
- Therapeutic goods regulation (24)
- Manufacturing (22)
- Assessed listed medicines (21)
- Complementary medicines (21)
- Scheduling (national classification system) (21)
- Unapproved therapeutic goods (17)
- Labelling and packaging (15)
- Safety (13)
- Medicinal cannabis hub (10)
- Nicotine vaping products hub (10)
- Shortages (10)
- Over the counter medicine (9)
- Import and export (8)
- Sunscreens (8)
- Australian Register of Therapeutic Goods (ARTG) (7)
- In Vitro Diagnostic medical devices (IVDs) (7)
- Alert/Advisory (4)
- Compliance and enforcement hub (3)
- Advisory bodies and committees (2)
- Biologicals (2)
- Fees and payments (2)
- Weight loss products (2)
- Biological medicines (1)
- Blood and blood components (1)
- Blood safety (1)
- Clinical trials (1)
- Cosmetics (1)
- Other therapeutic goods (1)
- Prescription opioids hub (1)
- Travelling with health products (1)
- Unique Device Identification (UDI) Hub (1)
Search
901 result(s) found, displaying 76 to 100
- NewsUpdates to the Prescribing Medicines in Pregnancy database, December 2022The Prescribing Medicines in Pregnancy database has now been updated.
- NoticesTherapeutic Goods (Biologicals-Application Form for Priority Applicant Determinations) Approval 2022Approval of the Therapeutic Goods (Biologicals—Application Form for Priority Applicant Determinations)
- NewsA reminder about weight loss productsBefore you take a weight loss supplement or medicine, there are things to consider.
- COVID-19 vaccine safety reportsCOVID-19 vaccine safety report - 15-12-2022Information about the TGA's safety monitoring of COVID-19 vaccines.
- BlogPrevent paracetamol poisoning in your homeMake small changes to how you think about paracetamol.
- Safety updatesProduct Information safety updates - November 2022Medicines Safety Update - Information for health professionals
- NewsCOVID-19 treatment: Gilead Sciences Pty Ltd, remdesivir (VEKLURY)On 10 July 2020 the Therapeutic Goods Administration (TGA) granted provisional approval to remdesivir ("Veklury", Gilead Sciences Pty Ltd) as the first treatment option for COVID-19
- NewsCOVID-19 treatment: GlaxoSmithKline Australia Pty Ltd, sotrovimab (XEVUDY)On 20 August 2021 the TGA granted provisional approval to GlaxoSmithKline Australia Pty Ltd in relation to sotrovimab (XEVUDY).
- COVID-19 vaccine safety reportsCOVID-19 vaccine safety report - 01-12-2022Information about the TGA's safety monitoring of COVID-19 vaccines.
- NewsA warning that advertising Ozempic (semaglutide) is prohibitedA warning to social media influencers and advertisers not to advertise this prescription medicine.
- Media releasesTGA consults on potential nicotine vaping product regulatory reformsThe TGA is seeking public comment on potential reforms to the regulation of nicotine vaping products in Australia.
- NoticesUpdate to listed medicine ingredients in November 2022Listed medicine ingredients and requirements are updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 5) 2022.
- Media releasesMedical practitioner fined $2,664 for alleged unlawful advertising of nicotine vaping productsThe TGA has issued an infringement notice of $2,664 to a NSW-based medical practitioner for alleged unlawful advertising of nicotine vaping products in a social media post.
- COVID-19 vaccine safety reportsCOVID-19 vaccine safety report - 17-11-2022Information about the TGA's safety monitoring of COVID-19 vaccines.
- Media releasesTGA grants provisional determination to Pfizer’s COVID-19 bivalent (COMIRNATY BIVALENT OMICRON BA.4/BA.5) booster dose vaccineThe TGA has granted a provisional determination to Pfizer's bivalent COVID-19 vaccine candidate: tozinameran & famtozinameran (COMIRNATY BIVALENT OMICRON BA.4/BA.5 COVID-19 VACCINE).
- NoticesTherapeutic Goods (Adverse Events Management System - Adverse Events Following Immunisation) (Arrangement for Computer Programs) Instrument 2022Arrangement under subsection 7C(1) of the Therapeutic Goods Act 1989 for use of computer programs to make decisions under sections 61(3)(a), 61(5AA), and 61(5AB) of the Act
- Media releasesAus Labs, Smart Labs, iSARMs and Director Christopher Ramsey plead guilty to over 200 charges for illegal manufacture, supply and advertising of SARMs and nootropicsOn 25 October 2022, Natural Franchises Pty Ltd pleaded guilty in a Sydney court to over 200 offences of the Therapeutic Goods Act 1989 for the manufacture, supply and advertising of unapproved therapeutic goods.
- Media releasesPhilips’ recall action for sleep apnoea and respiratory care machines – have you registered for a replacement?The TGA is calling for anyone using a Philips Continuous Positive Airway Pressure (CPAP) machine or a Bi-level Positive Airway Pressure (Bi-Level PAP) machine to see if they are affected by the recall action.
- COVID-19 vaccine safety reportsCOVID-19 vaccine safety report - 03-11-2022Information about the TGA's safety monitoring of COVID-19 vaccines.
- NewsStandard for serialisation and data matrix codes commences 1 January 2023Find out about the requirements starting on 1 January 2023 for medicines that are serialised or include a data matrix code.
- Media releasesIMUNI Pty Ltd fined $13,320 for alleged unlawful advertising of a complementary medicineThe TGA has issued one infringement notice to Queensland-based IMUNI Pty Ltd for allegedly advertising a complementary medicine for a therapeutic use that was not permitted.
- Safety updatesProduct Information safety updates - September and October 2022Medicines Safety Update - Information for health professionals.
- Media releasesTwo medicinal cannabis clinics fined $239,760 for alleged unlawful advertisingThe TGA has issued infringement notices for the alleged unlawful advertising of medicinal cannabis products on their websites and social media platforms.
- Media releasesWest Australian health practitioner fined $13,320 for alleged unlawful advertising of medicinal cannabisThe TGA has issued infringement notices for the alleged unlawful advertising of medicinal cannabis products on a website and through social media.
- NewsBeware the Barbie drug: the dangers of using MelanotanThe TGA urges consumers to steer clear of using products containing 'Melanotan'